Evidence mapPaperPMID 41867255Full record

ReviewCardiology discovery2026

Endocytic Adaptor Proteins in Vascular Diseases: Critical Role of Intracellular Trafficking in Regulating Pathobiology of Vascular Disorders.

Jianing Gao, Bo Zhu, Beibei Wang, Bandana Singh, Shahram Eisa-Beygi, Hao Wu, Kui Cui, Kulandai Samy Arulsamy, Wendong Huang, Wenyi Wei and 2 more

Abstract readReview
In one paragraph

Review in Cardiology discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jianing GaoVascular Biology Program, Harvard Medical School, Boston Children's Hospital and Department of Surgery, Boston, Massachusetts 02115, USA.
Bo ZhuVascular Biology Program, Harvard Medical School, Boston Children's Hospital and Department of Surgery, Boston, Massachusetts 02115, USA.
Beibei WangVascular Biology Program, Harvard Medical School, Boston Children's Hospital and Department of Surgery, Boston, Massachusetts 02115, USA.
Bandana SinghVascular Biology Program, Harvard Medical School, Boston Children's Hospital and Department of Surgery, Boston, Massachusetts 02115, USA.
Shahram Eisa-BeygiVascular Biology Program, Harvard Medical School, Boston Children's Hospital and Department of Surgery, Boston, Massachusetts 02115, USA.
Hao WuVascular Biology Program, Harvard Medical School, Boston Children's Hospital and Department of Surgery, Boston, Massachusetts 02115, USA.
Kui CuiVascular Biology Program, Harvard Medical School, Boston Children's Hospital and Department of Surgery, Boston, Massachusetts 02115, USA.
Kulandai Samy ArulsamyVascular Biology Program, Harvard Medical School, Boston Children's Hospital and Department of Surgery, Boston, Massachusetts 02115, USA.
Wendong HuangDivision of Molecular Diabetes Research, Department of Diabetes and Metabolic Diseases, City of Hope National Medical Center, Duarte, California 91010, USA.
Wenyi WeiDepartment of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
Prasad Vg KatakamDepartment of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana 70112, USA.
Hong ChenVascular Biology Program, Harvard Medical School, Boston Children's Hospital and Department of Surgery, Boston, Massachusetts 02115, USA.

Funding

The role of signaling adaptor protein epsin in atherosclerosisR01HL156362 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI Hong Chen, Jinjun Shi · 2022 to 2024
$2.3M
The Role of Adaptor Protein Disabled-2 in Maintaining Endothelial Cell Function in AtherosclerosisR01HL162367 · NHLBI · BOSTON CHILDREN'S HOSPITAL · 2023 to 2025
$2.2M
CD45-mediated endothelial-to-mesenchymal transition in cardiovascular diseaseR01HL141853 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI Hong Chen, Da-Zhi Wang · 2022 to 2023
$1.7M
Role of PXR in drug-elicited cardiovascular diseaseR01HL167206 · NHLBI · UNIVERSITY OF CALIFORNIA RIVERSIDE · 2024 to 2025
$1.4M
Controlling Neuropilin-2 Signaling to Improve Lymphatic FunctionR01HL179216 · BOSTON CHILDREN'S HOSPITAL · 2025 to 2025
$866k
Targeting PCBP1 to Ameliorate Pathological AngiogenesisR01HL179278 · UNIVERSITY OF SOUTHERN CALIFORNIA · 2025 to 2025
$790k
A New-Generation Lipid-Lowering and Anti-Inflammatory siRNA Therapy for AtherosclerosisR01HL177519 · BRIGHAM AND WOMEN'S HOSPITAL · 2025 to 2025
$787k
Targeting Endothelial Epsins to Ameliorate Myocardial IschemiaR01HL174928 · BOSTON CHILDREN'S HOSPITAL · 2025 to 2025
$776k
NHLBI NIH HHS R01 HL141853NHLBI NIH HHS R01 HL156362NHLBI NIH HHS R01 HL158097NHLBI NIH HHS R01 HL162367NHLBI NIH HHS R01 HL167206NHLBI NIH HHS R01 HL174928NHLBI NIH HHS R01 HL177519NHLBI NIH HHS R01 HL179216NHLBI NIH HHS R01 HL179278
6 · The paper itself

Abstract

Endocytic adaptor proteins are essential regulators of intracellular trafficking, coupling receptor internalization with downstream signaling. Recent discoveries have deepened our understanding of how endocytic adaptor proteins contribute to both physiological and pathological processes in the vascular system. This review summarizes the emerging roles of key adaptor proteins-such as epsins, disabled-2, and adaptor protein 2-across multiple vascular cell types, including endothelial cells, vascular smooth muscle cells, and macrophages. These adaptors have diverse but essential functions, ranging from regulating angiogenic signaling and maintaining endothelial barrier integrity to modulating inflammatory responses, vascular smooth muscle cells phenotypic switching, lipid uptake, and structural remodeling of blood vessels. We also highlight advances in therapeutic strategies, such as nanomedicine, viral expression vectors, DNA nanostructures, and small molecule inhibitors that target endocytic adaptors and their function. Understanding the diverse and cell-specific roles of endocytic adaptor proteins is important for gaining insights into vascular disease mechanisms and uncovering novel targets for therapeutic interventions.

Indexed as

Cardiovascular diseaseEndocytic adaptor proteinsEndocytosisEndothelial dysfunctionEpsinNanoparticles

Identifiers

PMID41867255
PMCPMC13003415

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.